These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

242 related articles for article (PubMed ID: 24070213)

  • 1. Downregulation of KPNA2 in non-small-cell lung cancer is associated with Oct4 expression.
    Li XL; Jia LL; Shi MM; Li X; Li ZH; Li HF; Wang EH; Jia XS
    J Transl Med; 2013 Sep; 11():232. PubMed ID: 24070213
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Aberrant expression of KPNA2 is associated with a poor prognosis and contributes to OCT4 nuclear transportation in bladder cancer.
    Zhou J; Dong D; Cheng R; Wang Y; Jiang S; Zhu Y; Fan L; Mao X; Gui Y; Li Z; Li X; Shi B
    Oncotarget; 2016 Nov; 7(45):72767-72776. PubMed ID: 27611951
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Quantitative proteomics reveals regulation of karyopherin subunit alpha-2 (KPNA2) and its potential novel cargo proteins in nonsmall cell lung cancer.
    Wang CI; Chien KY; Wang CL; Liu HP; Cheng CC; Chang YS; Yu JS; Yu CJ
    Mol Cell Proteomics; 2012 Nov; 11(11):1105-22. PubMed ID: 22843992
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Karyopherin alpha 2 is a novel prognostic marker and a potential therapeutic target for colon cancer.
    Zhang Y; Zhang M; Yu F; Lu S; Sun H; Tang H; Peng Z
    J Exp Clin Cancer Res; 2015 Dec; 34():145. PubMed ID: 26626145
    [TBL] [Abstract][Full Text] [Related]  

  • 5. MiR-26b/KPNA2 axis inhibits epithelial ovarian carcinoma proliferation and metastasis through downregulating OCT4.
    Lin J; Zhang L; Huang H; Huang Y; Huang L; Wang J; Huang S; He L; Zhou Y; Jia W; Yun J; Luo R; Zheng M
    Oncotarget; 2015 Sep; 6(27):23793-806. PubMed ID: 26204489
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nuclear accumulation of KPNA2 impacts radioresistance through positive regulation of the PLSCR1-STAT1 loop in lung adenocarcinoma.
    Liao WC; Lin TJ; Liu YC; Wei YS; Chen GY; Feng HP; Chang YF; Chang HT; Wang CL; Chi HC; Wang CI; Lin KH; Ou Yang WT; Yu CJ
    Cancer Sci; 2022 Jan; 113(1):205-220. PubMed ID: 34773335
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Importin subunit alpha-2 is identified as a potential biomarker for non-small cell lung cancer by integration of the cancer cell secretome and tissue transcriptome.
    Wang CI; Wang CL; Wang CW; Chen CD; Wu CC; Liang Y; Tsai YH; Chang YS; Yu JS; Yu CJ
    Int J Cancer; 2011 May; 128(10):2364-72. PubMed ID: 20658535
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Putative stemness markers octamer-binding transcription factor 4, sex-determining region Y-box 2, and NANOG in non-small cell lung carcinoma: A clinicopathological association.
    Upadhyay VA; Shah KA; Makwana DP; Raval AP; Shah FD; Rawal RM
    J Cancer Res Ther; 2020; 16(4):804-810. PubMed ID: 32930122
    [TBL] [Abstract][Full Text] [Related]  

  • 9. mTOR regulates proteasomal degradation and Dp1/E2F1- mediated transcription of KPNA2 in lung cancer cells.
    Wang CI; Chen YY; Wang CL; Yu JS; Chang YS; Yu CJ
    Oncotarget; 2016 May; 7(18):25432-42. PubMed ID: 27009856
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Oct4 transcriptionally regulates the expression of long non-coding RNAs NEAT1 and MALAT1 to promote lung cancer progression.
    Jen J; Tang YA; Lu YH; Lin CC; Lai WW; Wang YC
    Mol Cancer; 2017 Jun; 16(1):104. PubMed ID: 28615056
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identification of karyopherin-alpha 2 as an Oct4 associated protein.
    Li X; Sun L; Jin Y
    J Genet Genomics; 2008 Dec; 35(12):723-8. PubMed ID: 19103427
    [TBL] [Abstract][Full Text] [Related]  

  • 12. KPNA2 interacts with P65 to modulate catabolic events in osteoarthritis.
    Tao R; Xu X; Sun C; Wang Y; Wang S; Liu Z; Zhai L; Cheng H; Xiao M; Zhang D
    Exp Mol Pathol; 2015 Oct; 99(2):245-52. PubMed ID: 26209501
    [TBL] [Abstract][Full Text] [Related]  

  • 13. MiR-101-3p targets KPNA2 to inhibit the progression of lung squamous cell carcinoma cell lines.
    Dong L; Jiang H; Qiu T; Xu Y; Chen E; Huang A; Ying K
    Histol Histopathol; 2023 Oct; 38(10):1169-1178. PubMed ID: 36583484
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Overexpression of TRIM24 correlates with tumor progression in non-small cell lung cancer.
    Li H; Sun L; Tang Z; Fu L; Xu Y; Li Z; Luo W; Qiu X; Wang E
    PLoS One; 2012; 7(5):e37657. PubMed ID: 22666376
    [TBL] [Abstract][Full Text] [Related]  

  • 15. KPNA2 promotes cell proliferation and tumorigenicity in epithelial ovarian carcinoma through upregulation of c-Myc and downregulation of FOXO3a.
    Huang L; Wang HY; Li JD; Wang JH; Zhou Y; Luo RZ; Yun JP; Zhang Y; Jia WH; Zheng M
    Cell Death Dis; 2013 Aug; 4(8):e745. PubMed ID: 23907459
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Regulation of Sox2 and stemness by nicotine and electronic-cigarettes in non-small cell lung cancer.
    Schaal CM; Bora-Singhal N; Kumar DM; Chellappan SP
    Mol Cancer; 2018 Oct; 17(1):149. PubMed ID: 30322398
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Overexpression of karyopherin-α2 in cholangiocarcinoma correlates with poor prognosis and gemcitabine sensitivity via nuclear translocation of DNA repair proteins.
    Tsukagoshi M; Araki K; Yokobori T; Altan B; Suzuki H; Kubo N; Watanabe A; Ishii N; Hosouchi Y; Nishiyama M; Shirabe K; Kuwano H
    Oncotarget; 2017 Jun; 8(26):42159-42172. PubMed ID: 28178675
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Association of overexpressed karyopherin alpha 2 with poor survival and its contribution to interleukin-1β-induced matrix metalloproteinase expression in oral cancer.
    Wang CI; Yu CJ; Huang Y; Yi JS; Cheng HW; Kao HK; Lao WW; Chang KP
    Head Neck; 2018 Aug; 40(8):1719-1733. PubMed ID: 29542209
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Overexpression of karyopherin-2 in epithelial ovarian cancer and correlation with poor prognosis.
    Zheng M; Tang L; Huang L; Ding H; Liao WT; Zeng MS; Wang HY
    Obstet Gynecol; 2010 Oct; 116(4):884-891. PubMed ID: 20859152
    [TBL] [Abstract][Full Text] [Related]  

  • 20. KPNA2 is a promising biomarker candidate for esophageal squamous cell carcinoma and correlates with cell proliferation.
    Ma S; Zhao X
    Oncol Rep; 2014 Oct; 32(4):1631-7. PubMed ID: 25109899
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.